Contact
DMCA
Privacy
Robuta
https://www.mdpi.com/2077-0383/12/16/5252
Dinutuximab Beta Maintenance Therapy in Patients with High-Risk Neuroblastoma in First-Line and...
Dinutuximab beta is approved for the maintenance treatment of patients with high-risk neuroblastoma (HR-NB), including patients with relapsed/refractory (R/R)...
dinutuximab beta
maintenance therapy
high risk
patients
neuroblastoma